FR3004184B1 - Anticorps anti-gluten desamide et utilisations. - Google Patents

Anticorps anti-gluten desamide et utilisations.

Info

Publication number
FR3004184B1
FR3004184B1 FR1353178A FR1353178A FR3004184B1 FR 3004184 B1 FR3004184 B1 FR 3004184B1 FR 1353178 A FR1353178 A FR 1353178A FR 1353178 A FR1353178 A FR 1353178A FR 3004184 B1 FR3004184 B1 FR 3004184B1
Authority
FR
France
Prior art keywords
desamide
gluten antibody
gluten
antibody
antibody desamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1353178A
Other languages
English (en)
Other versions
FR3004184A1 (fr
Inventor
Sandra Denery
Olivier Tranquet
Colette Larre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1351685A external-priority patent/FR3004183A1/fr
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Priority to FR1353178A priority Critical patent/FR3004184B1/fr
Priority to EP14708699.5A priority patent/EP2961769A1/fr
Priority to PCT/IB2014/059269 priority patent/WO2014132204A1/fr
Priority to US14/770,464 priority patent/US20160108107A1/en
Publication of FR3004184A1 publication Critical patent/FR3004184A1/fr
Application granted granted Critical
Publication of FR3004184B1 publication Critical patent/FR3004184B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
FR1353178A 2013-02-26 2013-04-09 Anticorps anti-gluten desamide et utilisations. Expired - Fee Related FR3004184B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1353178A FR3004184B1 (fr) 2013-02-26 2013-04-09 Anticorps anti-gluten desamide et utilisations.
EP14708699.5A EP2961769A1 (fr) 2013-02-26 2014-02-26 Anticorps anti-gluten desamide et utilisations
PCT/IB2014/059269 WO2014132204A1 (fr) 2013-02-26 2014-02-26 Anticorps anti-gluten desamide et utilisations
US14/770,464 US20160108107A1 (en) 2013-02-26 2014-02-26 Deamidated anti-gluten antibody and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1351685A FR3004183A1 (fr) 2013-02-26 2013-02-26 Anticorps anti-gluten desamide et utilisations.
FR1353178A FR3004184B1 (fr) 2013-02-26 2013-04-09 Anticorps anti-gluten desamide et utilisations.

Publications (2)

Publication Number Publication Date
FR3004184A1 FR3004184A1 (fr) 2014-10-10
FR3004184B1 true FR3004184B1 (fr) 2016-03-18

Family

ID=50238436

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1353178A Expired - Fee Related FR3004184B1 (fr) 2013-02-26 2013-04-09 Anticorps anti-gluten desamide et utilisations.

Country Status (4)

Country Link
US (1) US20160108107A1 (fr)
EP (1) EP2961769A1 (fr)
FR (1) FR3004184B1 (fr)
WO (1) WO2014132204A1 (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4424200A (en) 1979-05-14 1984-01-03 Nuc Med Inc. Method for radiolabeling proteins with technetium-99m
DE2930706A1 (de) 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
US4479930A (en) 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
PT92900A (pt) 1989-01-24 1990-07-31 Sistema de vectores de expressao para a producao de anticorpos monoclonais quimericos
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1994004679A1 (fr) 1991-06-14 1994-03-03 Genentech, Inc. Procede pour fabriquer des anticorps humanises
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
EP1332760A1 (fr) * 2002-02-04 2003-08-06 Academisch Ziekenhuis Leiden Nouveaux épitopes de la maladie coeliaque et de maladies autoimmunes; méthodes de détection de ces épitopes et de nouveaux composés alimentaires non-antigéniques
JP5937106B2 (ja) * 2011-01-20 2016-06-22 サイレックス ラボラトリーズ，エルエルシー グルテン感受性の検出およびグルテン感受性とセリアック病を鑑別するための方法ならびに装置

Also Published As

Publication number Publication date
US20160108107A1 (en) 2016-04-21
EP2961769A1 (fr) 2016-01-06
WO2014132204A1 (fr) 2014-09-04
WO2014132204A9 (fr) 2018-10-11
FR3004184A1 (fr) 2014-10-10

Similar Documents

Publication Publication Date Title
FR23C1019I2 (fr) Anticorps anti-complément c1s et utilisations de ceux-ci
MA49537A (fr) Anticorps anti-lag3 et leurs utilisations
MA47694A (fr) Anticorps anti-tigit
MA49034A (fr) Anticorps anti-lag3
CL2015001924A1 (es) Anticuerpos anti-pdgfr-beta y usos relacionados.
CL2016000680A1 (es) Formulaciones de anticuerpos anti-pdl1.
CL2016001646A1 (es) Anticuerpos y fragmentos anti-vista
MA47268A (fr) Anticorps anti-gpc3
MA47472A (fr) Anticorps
DK2970460T3 (da) Anti-IL-33-antistoffer og anvendelser deraf
MA45125A (fr) Anticorps anti-alpha-synucléine et leurs utilisations
CL2016001102A1 (es) Anticuerpos anti-claudina novedosos y métodos de uso.
MA45690A (fr) Anticorps anti-tgfb, méthodes et utilisations
DK3027209T3 (da) Anti-Activin A-antistoffer og anvendelser deraf
DK3336106T3 (da) Anti-fcrh5-antistoffer
BR112014030278A2 (pt) anticorpo, e, composição.
FR3006466B3 (fr) .
CL2015003496A1 (es) Anticuerpos teicoicos anti-pared y conjugados.
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
MA45233A (fr) Anticorps anti-gitr et leurs utilisations
IL244043B (en) Antibodies against CSF-1r and their use.
MA42843A (fr) Anticorps anti-cd115
DK3003386T3 (da) Antistoflægemiddelkonjugater
MA43814A (fr) Anticorps anti-gitr, méthodes et utilisations
DK3052522T3 (da) Anti-sox 10 antistofsystemer og -fremgangsmåder

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20200108